TY - JOUR
T1 - Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis
AU - Surmann, Marian
AU - Falke, Sebastian
AU - von Gruchalla, Lara
AU - Maisch, Birgit
AU - Uhlmann, Christina
AU - Arolt, Volker
AU - Lencer, Rebekka
N1 - Funding Information:
The authors are grateful to all participants for their willingness to contribute to this study. We thank Karen Rolfes, MD, Franziska Fey, MSc and Tobias Feldhaus, MD, for their assistance in recruitment procedures. No funding source.
Publisher Copyright:
© 2020 Elsevier B.V.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/1
Y1 - 2021/1
N2 - There is an urgent need for a better understanding of the multidimensional factors of medication adherence attitudes in patients with psychosis in order to enhance adherence as up to 75% of patients stop or change their medication within a year. 81 patients with psychosis were assessed on symptom expression, self-stigmatization, adherence attitudes, QoL, social support and therapeutic alliance judged by patients and clinicians. Regression analyses were used to test whether better QoL, more social support and a better therapeutic alliance are associated with more positive and less negative adherence attitudes. More positive clinician input, higher state anxiety and lower levels of self-stigmatization predicted more positive adherence attitudes, while less positive collaboration with the clinician and higher levels of self-stigmatization were associated with more negative adherence attitudes. QoL and social support were unrelated to adherence attitudes. The quality of the therapeutic alliance perceived by patients appears crucial regarding their medication adherence attitudes. Thus, clinicians’ focus on psychotic symptom expression is not sufficient to achieve goal agreement. Rather, it is imperative to consider the individual subjective needs of patients as a key element for sustained therapeutic alliance.
AB - There is an urgent need for a better understanding of the multidimensional factors of medication adherence attitudes in patients with psychosis in order to enhance adherence as up to 75% of patients stop or change their medication within a year. 81 patients with psychosis were assessed on symptom expression, self-stigmatization, adherence attitudes, QoL, social support and therapeutic alliance judged by patients and clinicians. Regression analyses were used to test whether better QoL, more social support and a better therapeutic alliance are associated with more positive and less negative adherence attitudes. More positive clinician input, higher state anxiety and lower levels of self-stigmatization predicted more positive adherence attitudes, while less positive collaboration with the clinician and higher levels of self-stigmatization were associated with more negative adherence attitudes. QoL and social support were unrelated to adherence attitudes. The quality of the therapeutic alliance perceived by patients appears crucial regarding their medication adherence attitudes. Thus, clinicians’ focus on psychotic symptom expression is not sufficient to achieve goal agreement. Rather, it is imperative to consider the individual subjective needs of patients as a key element for sustained therapeutic alliance.
UR - http://www.scopus.com/inward/record.url?scp=85097426834&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/7ec8d3a2-cb2e-310f-ad9c-06f2adc2a517/
U2 - 10.1016/j.psychres.2020.113601
DO - 10.1016/j.psychres.2020.113601
M3 - Journal articles
C2 - 33296816
AN - SCOPUS:85097426834
SN - 0165-1781
VL - 295
SP - 113601
JO - Psychiatry Research
JF - Psychiatry Research
M1 - 113601
ER -